CSF levels of PSA and PSA-ACT complexes in Alzheimer's disease

Annals of Clinical Biochemistry

Volumn 46, Issue 6, 2009, Pages 477-483

  Mulder, Sandra D ^a,b   Heijst, Johannes A ^a,b   Mulder, Cees ^a,b   Martens, Frans ^a   Hack, C Erik ^a   Scheltens, Philip ^a,b   Blankenstein, Marinus A ^a,b   Veerhuis, Robert ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; PROSTATE SPECIFIC ANTIGEN;

ALZHEIMER DISEASE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROL GROUP; CONTROLLED STUDY; DISEASE MARKER; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPORAL CORTEX;

ALPHA 1-ANTICHYMOTRYPSIN; ALZHEIMER DISEASE; BIOLOGICAL MARKERS; BRAIN; COGNITION DISORDERS; DEMENTIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FRONTAL LOBE; HUMANS; IMMUNOASSAY; MALE; PROSTATE-SPECIFIC ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROMETRY, FLUORESCENCE; TEMPORAL LOBE;

EID: 73449146628     PISSN: 00045632     EISSN: 00045632     Source Type: Journal    
DOI: 10.1258/acb.2009.009130     Document Type: Article

References (43)

1. Abraham CR, Shirahama T, Potter H. Alpha 1-antichymotrypsin is associated solely with amyloid deposits containing the beta-protein. Amyloid and cell localization of alpha 1-antichymotrypsin. Neurobiol Aging 1990;11:123-9
2. Pasternack JM, Abraham CR, Van Dyke BJ, Potter H, Younkin SG. Astrocytes in Alzheimer's disease gray matter express alpha 1-antichymotrypsin mRNA. Am J Pathol 1989;135:827-34
3. Nilsson LN, Bales KR, DiCarlo G, et al. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J Neurosci 2001;21:1444-51
4. Mucke L, Yu GQ, McConlogue L, Rockenstein EM, Abraham CR, Masliah E. Astroglial expression of human alpha(1)-antichymotrypsin enhances Alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol 2000;157:2003-10
5. Potter H, Nelson RB, Das S, Siman R, Kayyali US, Dressler D. The involvement of proteases, protease inhibitors, and an acute phase response in Alzheimer's disease. Ann N Y Acad Sci 1992;674:161-73
6. DeKosky ST, Ikonomovic MD, Wang X, et al. Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment. Ann Neurol 2003;53:81-90
7. Licastro F, Parnetti L, Morini MC, et al. Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease. Alzheimer Dis Assoc Disord 1995;9:112-8
8. Matsubara E, Hirai S, Amari M, et al. Alpha 1-antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann Neurol 1990;28:561-7
9. Nielsen HM, Minthon L, Londos E, et al. Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodies. Neurology 2007;69: 1569-79
10. Dik MG, Jonker C, Hack CE, Smit JH, Comijs HC, Eikelenboom P. Serum inflammatory proteins and cognitive decline in older persons. Neurology 2005;64:1371-7
11. Diamandis EP, Yu H. Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 1997;24:275-82
12. Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007;53:1423-32
13. Stone JG, Rolston RK, Ueda M, et al. Evidence for the novel expression of human Kallikrein-related Peptidase 3, prostate-specific antigen, in the brain. Int J Clin Exp Pathol 2009;2:267-74
14. Wolff JM, Borchers H, Kunitz O, Planz B, Jakse G. Prostate-specific antigen immunoreactivity in spinal fluid. Urol Int 1997;59:236-8
15. Melegos DN, Freedman MS, Diamandis EP. Prostate-specific antigen in cerebrospinal fluid. Clin Chem 1997;43:855
16. Morote J, Ruibal A, Boada M. Behavior of prostatic specific antigen (PSA) in spinal fluid: its correlation with serum levels. Int J Biol Markers 1986;1:109-10
17. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6
18. Okada K, Kojima M, Naya Y, et al. Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000;55:892-8
19. Akiyama H, Barger S, Barnum S, et al. Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421
20. Bouwman FH, van der Flier WM, Schoonenboom NS, et al. Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology 2007;69:1006-11
21. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 2001;310:173-86
22. Blennow K, Fredman P, Wallin A, et al. Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age. Eur Neurol 1993;33:129-33
23. Schuitemaker A, Dik MG, Veerhuis R, et al. Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging 2008;Epub ahead of print. DOI: 10.1016/j.neurobiolaging.2008.01.014
24. Rozemuller JM, Abbink JJ, Kamp AM, Stam FC, Hack CE, Eikelenboom P. Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. Acta Neuropathol 1991;82:200-7
25. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
26. Tetin SY, Ruan Q, Saldana SC, et al. Interactions of two monoclonal antibodies with BNP: high resolution epitope mapping using fluorescence correlation spectroscopy. Biochemistry 2006;45:14155- 65
27. Felgenhauer K, Beuche W. Labordiagnostik neurologischer Erkrankungen: Liquoranalytik und - zytologie, Diagnose - und Prozeßmarker. Stuttgart: Thieme, 1999
28. Felgenhauer K. Protein size and cerebrospinal fluid composition. Klin Wochenschr 1974;52:1158-64
29. Gan L, Lee I, Smith R, et al. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region. Gene 2000;257:119-30
30. Sheridan T, Herawi M, Epstein JI, Illei PB. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Am J Surg Pathol 2007;31:1351-5
31. Shimizu-Okabe C, Yousef GM, Diamandis EP, Yoshida S, Shiosaka S, Fahnestock M. Expression of the kallikrein gene family in normal and Alzheimer's disease brain. Neuroreport 2001;12:2747-51
32. Tortorella C, Codella M, Rocca MA, et al. Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging. J Neurol 1999;246:689-92
33. de Vries HE, Kuiper J, de Boer AG, Van Berkel TJ, Breimer DD. The blood-brain barrier in neuroinflammatory diseases. Pharmacol Rev 1997;49:143-55
34. Yu H, Diamandis EP. Measurement of serum prostate specific antigen levels in women and in prostatectomized men with an ultrasensitive immunoassay technique. J Urol 1995;153:1004-8
35. Diamandis EP, Yu H. New biological functions of prostate-specific antigen? J Clin Endocrinol Metab 1995;80:1515-7
36. Delamarche C, Berger F, Gallard L, Pouplard-Barthelaix A. Aging and Alzheimer's disease: protease inhibitors in cerebrospinal fluid. Neurobiol Aging 1991;12:71-4
37. Pirttila T, Mehta PD, Frey H, Wisniewski HM. Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease. Neurobiol Aging 1994;15:313-7
38. Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci 2003;21:79-96
39. Winkler F, Gschwendtner A, Theisen D, Peraud A, Straube A. Reversible dementia and corresponding CSF alterations due to intraspinal lumbosacral metastasis of a prostate carcinoma. Eur J Neurol 2007;14:1400-2
40. Schaller B, Merlo A, Kirsch E, et al. Prostate-specific antigen in the cerebrospinal fluid leads to diagnosis of solitary cauda equina metastasis: a unique case report and review of the literature. Br J Cancer 1998;77:2386-9
41. Pettersson K, Piironen T, Seppala M, et al. Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex. Clin Chem 1995;41:1480-8
42. Allard WJ, Zhou Z, Yeung KK. Novel immunoassay for the measurement of complexed prostate-specific antigen in serum. Clin Chem 1998;44:1216-23
43. Lilja H, Christensson A, Dahlen U, et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991;37:1618-25